| Covid-19 and sickle cell anemia: susceptibility and severity EI Obeagu, Q Babar J. Clinical and Laboratory Research 3 (5), 2768-0487, 2021 | 52 | 2021 |
| Allergic blood Transfusion reaction: A Review EI Obeagu, Q Babar, GU Obeagu Int. J. Curr. Res. Med. Sci 7 (5), 25-33, 2021 | 35 | 2021 |
| An Update on Transfusion Related Immunomodulation (TRIM) in a Time of COVID-19 Pandemic EI Obeagu, Q Babar, IO Uduchi, AM Ibekwe, UO Chijioke, CJ Okafor, ... Journal of Pharmaceutical Research International 33 (42A), 135-146, 2021 | 32 | 2021 |
| Pulmonary Embolism in Covid-19 Pandemic: A Threat to Recovery of the Infected Patients EI Obeagu, Q Babar, CCN Vincent, CJ Okafor, R Eze, UO Chijioke, ... Journal of Pharmaceutical Research International 33 (42A), 90-98, 2021 | 26 | 2021 |
| Targeting the tumor microenvironment: Potential strategy for cancer therapeutics Q Babar, A Saeed, TA Tabish, M Sarwar, ND Thorat Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1869 (6), 166746, 2023 | 19 | 2023 |
| Therapeutic targets in breast cancer signaling: a review EI Obeagu, Q Babar, CCN Vincent, CL Udenze, R Eze, CJ Okafor, ... Journal of Pharmaceutical Research International 33 (56A), 82-99, 2021 | 18 | 2021 |
| Novel treatment strategy against COVID-19 through anti-inflammatory, antioxidant and immunostimulatory properties of the b vitamin complex Q Babar, A Ali, A Saeed, MF Tahir B-Complex Vitamins-Sources, Intakes and Novel Applications, 2021 | 18 | 2021 |
| Novel epigenetic therapeutic strategies and targets in cancer Q Babar, A Saeed, TA Tabish, S Pricl, H Townley, N Thorat Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1868 (12), 166552, 2022 | 16 | 2022 |
| Novel therapeutic drug strategies to tackle immune-oncological challenges faced by cancer patients during COVID-19 A Ali, H Mughal, N Ahmad, Q Babar, A Saeed, W Khalid, H Raza, A Liu Expert Review of Anticancer Therapy 21 (12), 1371-1383, 2021 | 14 | 2021 |
| Infants Immunization: Challenges of Other Vaccines Due To Covid-19 Pandemic EI Obeagu, Q Babar, CC Vincent, CO Anyanwu Journal of Bioinnovation 10 (4), 1056-66, 2021 | 12 | 2021 |
| Recent advances in understanding of Haemochromatosis: A burning issue of life EI Obeagu, Q Babar Int. J. Curr. Res. Med. Sci 7 (7), 23-28, 2021 | 11 | 2021 |
| In vitro human cancer models for biomedical applications JR Choi, G Kozalak, I Di Bari, Q Babar, Z Niknam, Y Rasmi, KW Yong Cancers 14 (9), 2284, 2022 | 7 | 2022 |
| Updates on Paroxysmal Nocturnal Haemoglobinuria EI Obeagu, CC Anierobi, Q Babar Int. J. Curr. Res. Med. Sci 7 (7), 14-22, 2021 | 7 | 2021 |
| Plasma Cell Leukaemia (PCL): A Review EI Obeagu, EC Udemezue, BO Akalonu, Q Babar Asian Hematology Research Journal 5 (3), 36-38, 2021 | 6 | 2021 |
| Metastasis Relapse in Synovial Sarcoma of Parotid Gland Followed by Neuropathies and Tissue Damage: A Case Report Q Babar, EI Obeagu, CL Udenze, BI Ifionu, CCN Vincent, CJ Okafor, ... Journal of Pharmaceutical Research International 33 (54A), 125-131, 2021 | 4 | 2021 |
| Increasing Fear Of Delta Variant Of New Coronavirus In Pakistan: Strict Actions Required To Wrestle The COVID-19 Peaks A Ali, A Saeed, Q Babar Updates in Emergency Medicine 1 (1), 52-53, 2021 | 3 | 2021 |
| Graft rejection after allogeneic bone marrow transplantation: A review EI Obeagu, Q Babar, CJ Okafor Int. J. Curr. Res. Med. Sci 7 (5), 1-9, 2021 | 3 | 2021 |
| Promise of dostarlimab in cancer therapy: Advancements and cross-talk considerations Q Babar, A Saeed, S Murugappan, D Dhumal, T Tabish, ND Thorat Drug Discovery Today 28 (6), 103577, 2023 | 2 | 2023 |
| Potential of ascorbic acid in human health against different diseases: an updated narrative review A Ali, S Riaz, W Khalid, M Fatima, U Mubeen, Q Babar, MF Manzoor, ... International Journal of Food Properties 27 (1), 493-515, 2024 | 1 | 2024 |
| AN UPDATE ON HAEMOPHILIA A EI Obeagu, RI Eze, A Nwakulite, GU Obeagu, Q Babar A. Journal of Medicine and Health Sciences 1 (1), 7-18, 2021 | 1 | 2021 |
